Yesterday was a good day... Nice to see a informational meeting from Cytodyn to the Philippines doctor(s).
I just have to say that next couple of weeks are going to be wonderful. We should have a few catalysts happen If everything goes as predicted. 1) I have to believe a uplist is pending soon. 2) Great mortality results possibly give us a immediate revenue from the Philippines. 3) Quick EUA from our FDA after submission.
The Philippines news wasn’t shy in their prediction for FDA approvals in the USA for us. They said 2-3 weeks for our EUA here and predicted it would be less than a week after we submit the unblinded data to the FDA. So in my eyes that could be even sooner but why push the days to EUA? Things are looking real good there!
I have to ponder what Janet Woodcock will do with the early mortality numbers and hopefully they are as awesome as we all hope. What will she do behind the scenes before the whole data report is submitted for EUA approval? Will she coordinate resources for us? Like put people on task with ASAP approvals of more bioreactors? Will she help us in other ways? Looks like we won’t be cash poor any longer after our first revenue. So money shouldn’t be needed. It looks to me that bioreactor approvals are the one thing holding us back from mass production of Vyrologix.
Let’s hope they put a whole department to task on quick bioreactor approvals. Let’s also hope that Samsung’s new expansion isn’t already filled up and booked with customers. Maybe that Cytodyn announces production capacities from Samsung that allow us to save lives around the world. That would be nice to hear.
Then I noticed that on the presentation to the Philippines that Enjay posted about cancer. The cancer BTD was to be submitted in the first quarter of 2021. Just when I was floating back to earth from all the good news. I see this and rocket back up into space. The presentation implied that just some needed testing to complete the application for the BTD needs to be completed. Then that will be filed.
I didn’t catch the HIV news of submitting BLAs around the world but I know it was talked about and I imagine they stated a loose date on that happening. I magine it will be by end of second quarter but not sure about that. It was implied once before
I believe.
I have to wonder just what the stock price will be if all things align in the next 6 months to a year. It’s looking like we are well in our way to becoming a big Pharmaceutical company in our own right. Especially after Nader said that is the future direction now. Not to split revenue and make partnership deals on distribution. To handle all sales in house. I couldn’t ask for better direction then the path we are in right now.
I haven’t been here as long as some. Only 18 months. But it’s been an exciting 18 months. Good luck to us all... good times are now upon us and the real life story is just beginning. Enjoy the ride.
I just have to say that next couple of weeks are going to be wonderful. We should have a few catalysts happen If everything goes as predicted. 1) I have to believe a uplist is pending soon. 2) Great mortality results possibly give us a immediate revenue from the Philippines. 3) Quick EUA from our FDA after submission.
The Philippines news wasn’t shy in their prediction for FDA approvals in the USA for us. They said 2-3 weeks for our EUA here and predicted it would be less than a week after we submit the unblinded data to the FDA. So in my eyes that could be even sooner but why push the days to EUA? Things are looking real good there!
I have to ponder what Janet Woodcock will do with the early mortality numbers and hopefully they are as awesome as we all hope. What will she do behind the scenes before the whole data report is submitted for EUA approval? Will she coordinate resources for us? Like put people on task with ASAP approvals of more bioreactors? Will she help us in other ways? Looks like we won’t be cash poor any longer after our first revenue. So money shouldn’t be needed. It looks to me that bioreactor approvals are the one thing holding us back from mass production of Vyrologix.
Let’s hope they put a whole department to task on quick bioreactor approvals. Let’s also hope that Samsung’s new expansion isn’t already filled up and booked with customers. Maybe that Cytodyn announces production capacities from Samsung that allow us to save lives around the world. That would be nice to hear.
Then I noticed that on the presentation to the Philippines that Enjay posted about cancer. The cancer BTD was to be submitted in the first quarter of 2021. Just when I was floating back to earth from all the good news. I see this and rocket back up into space. The presentation implied that just some needed testing to complete the application for the BTD needs to be completed. Then that will be filed.
I didn’t catch the HIV news of submitting BLAs around the world but I know it was talked about and I imagine they stated a loose date on that happening. I magine it will be by end of second quarter but not sure about that. It was implied once before
I believe.
I have to wonder just what the stock price will be if all things align in the next 6 months to a year. It’s looking like we are well in our way to becoming a big Pharmaceutical company in our own right. Especially after Nader said that is the future direction now. Not to split revenue and make partnership deals on distribution. To handle all sales in house. I couldn’t ask for better direction then the path we are in right now.
I haven’t been here as long as some. Only 18 months. But it’s been an exciting 18 months. Good luck to us all... good times are now upon us and the real life story is just beginning. Enjoy the ride.
9
